Skip to main content
Clinical Trials/ISRCTN82579275
ISRCTN82579275
Active, not recruiting
Phase 4

Occipitocervical spine stabilization using PERLA® posterior occipito-cervico-thoracic fixation. A post-market clinical follow-up study

Spineart (Switzerland)0 sites20 target enrollmentDecember 15, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Acute or chronic cranio-cervical junction instability due to, but not limited to: Trauma: Atlanto-occipital dislocation, occipital condyle fracture, atlas, and axis fractures
Sponsor
Spineart (Switzerland)
Enrollment
20
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2022
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Spineart (Switzerland)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who received the PERLA® Occipital system to treat a cranio\-cervical instability of any cause and indicated for occipito\-cervical fusion
  • 2\. Non\-opposition/consent for retrospective data collection

Exclusion Criteria

  • Current exclusion criteria as of 19/02/2024:
  • Does not meet the inclusion criteria.
  • Previous exclusion criteria:
  • Less than 6 months of post\-operative follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials